StockIQ.techQuest Diagnostics Incorporated (DGX) Stock Analysis
Free AI-powered analysis and research for Quest Diagnostics Incorporated stock
Sector: Healthcare
DGX snapshot
Data as of 3 Nov 2026 close. Updated daily.
Quest Diagnostics Incorporated scores 83/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 91% of its 52-week range, up 39.2% over the past year. Latest reported figures show a profit margin of 9.5%, return on equity of 15.3% and revenue growth of +10.0%.
What is driving the score
- Uptrend: +7
- MACD Bullish: +8
- Strong ROE (15.3%): +5
- Strong Long-term Uptrend: +8
- Strong Momentum (+39.2% over 1 year): +8
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full DGX report
Quest Diagnostics Incorporated (DGX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze DGX Now →📰 Latest Update
Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings
Sat, October 24, 2026 at 3:14 AM UTC 2 min read
Quest Diagnostics (DGX) experienced a stall in its stock price following the release of strong Q3 earnings. Despite reporting better-than-expected results, investor enthusiasm was tempered by concerns over future growth and market conditions. This development is significant for investors as it highlights the potential volatility in stock performance, even after positive earnings reports, underscoring the importance of broader market trends in investment decisions.